Cunningham A L, Basham T Y, Para M F, Merigan T C
J Interferon Res. 1985 Summer;5(3):477-91. doi: 10.1089/jir.1985.5.477.
Macrophage-T-lymphocyte cultures from patients with recent recurrent herpes labialis were stimulated to produce gamma interferon by either herpes simplex antigen or mitogens (PHA and Con A). The ability of monoclonal antibodies to HLA-DR and DC/DS, HSV glycoprotein antigens and T-lymphocyte surface antigens to inhibit interferon production and lymphocyte proliferation were studied. Anti-D region antibodies inhibited HSV antigen-induced but not mitogen-induced interferon and proliferation. The extent of inhibition varied mainly according to the determinants recognized by the antibodies and, to a lesser degree, between patients. Inhibition probably resulted from inhibition of antigen presentation, through antibody binding to macrophage D-region antigens. Interferon production was a more sensitive index of inhibition than lymphocyte proliferation. With one antibody (L227) a marked difference in inhibition in the two assays was noted, suggesting that lymphocytes producing gamma interferon may differ from the majority of the proliferating cells in their recognition of D-region determinants. Antibodies to the HSV glycoprotein antigens (gA/B, gC, gD, gE) did not produce consistent significant inhibition of interferon production and had no effect on proliferation. Anti-Leu 4 and -Leu 5 inhibited HSV antigen and mitogen induction of gamma interferon (and proliferation). Anti-Leu 2 and anti-Leu 3, mildly inhibitory alone, produced synergistic inhibition together. Hence, in human systems, the interaction between macrophages and T lymphocytes in producing gamma interferon appears to differ according to mode of induction. Macrophage D-region antigens are required for antigen induction probably via presentation whereas other factor(s), probably monokine secretion, are necessary for mitogen induction. Antibodies acting on the T-lymphocyte surface appear to affect a final common pathway of interferon induction, similar to their effects on proliferation and secretion of other lymphokines.
用单纯疱疹抗原或有丝分裂原(PHA和Con A)刺激近期复发性唇疱疹患者的巨噬细胞 - T淋巴细胞培养物,以产生γ干扰素。研究了针对HLA - DR和DC/DS、单纯疱疹病毒糖蛋白抗原以及T淋巴细胞表面抗原的单克隆抗体抑制干扰素产生和淋巴细胞增殖的能力。抗D区抗体抑制单纯疱疹病毒抗原诱导的干扰素产生和增殖,但不抑制有丝分裂原诱导的情况。抑制程度主要根据抗体识别的决定簇而有所不同,且在患者之间也有较小差异。抑制作用可能是由于抗体与巨噬细胞D区抗原结合,从而抑制了抗原呈递。干扰素产生比淋巴细胞增殖对抑制更为敏感。使用一种抗体(L227)时,在两种检测中发现抑制作用有明显差异,这表明产生γ干扰素的淋巴细胞在识别D区决定簇方面可能与大多数增殖细胞不同。针对单纯疱疹病毒糖蛋白抗原(gA/B、gC、gD、gE)的抗体并未对干扰素产生一致的显著抑制作用,且对增殖无影响。抗Leu 4和 - Leu 5抑制单纯疱疹病毒抗原和有丝分裂原诱导的γ干扰素产生(以及增殖)。抗Leu 2和抗Leu 3单独作用时轻度抑制,共同作用时产生协同抑制。因此,在人体系统中,巨噬细胞与T淋巴细胞在产生γ干扰素时的相互作用似乎因诱导方式而异。抗原诱导可能需要巨噬细胞D区抗原通过呈递作用,而有丝分裂原诱导则需要其他因素,可能是单核因子分泌。作用于T淋巴细胞表面的抗体似乎影响干扰素诱导的最终共同途径,类似于它们对其他淋巴因子增殖和分泌的影响。